Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Gastroenterologist
MBBS, FCPS (Medicine), FCPS (Gastroenterology), MRCP (LONDON) UK, European specialty examination in gastroenterology & Hepatology (ESG&H)
Gastroenterologist
MBBS, FCPS (Medicine), FCPS (Gastroenterology), MRCP (LONDON) UK, European specialty examination in gastroenterology & Hepatology (ESG&H)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Gastroenterologist
M.B.B.S., F.C.P.S (Gastroenterology), Advance Endoscopy Fellowship (USA)
Gastroenterologist
M.B.B.S., F.C.P.S (Gastroenterology), Advance Endoscopy Fellowship (USA)
Hepatologist
MBBS, MRCP (UK),, FRCP (Glasgow)
Internal Medicine Specialist
MBBS, MCPS (Family Medicine), MRCGP (Medicine), FRCGP
Consultant Physician
M.B.B.S, M.D (USA)
Internal Medicine Specialist
MBBS, FCPS
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures